Eminence Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-125,979
Closed -$16.4M 69
2020
Q4
$16.4M Buy
125,979
+23,710
+23% +$3.08M 0.15% 71
2020
Q3
$14.9M Sell
102,269
-79,304
-44% -$11.5M 0.15% 73
2020
Q2
$26.9M Buy
+181,573
New +$26.9M 0.27% 63